Search

everythinglearnresearchcommunity

for

Search:↓

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

Epimorphin helps shape and develop epithelial cells, like those in hair follicles.

The hydrogel treatment speeds up healing of chronic wounds.

Promising cancer treatments were found, but the manufacturer closed.

Provenge extends prostate cancer survival by about 4 months.

The ethosomal delivery system improves topical drug delivery and promotes hair growth.

SEPA 0009 is a promising and safe skin penetration enhancer for topical use.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

EFFC might be common but underreported.

Drying pomegranate peel is profitable and useful for various industries.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

The specific skin disease variant p.(Arg2000Trp) in plectin can cause a wide range of symptoms, which should be considered when diagnosing patients.

Ethosomes are effective, safe carriers for delivering drugs through the skin.

XP-endo Finisher R removes more root filling material than PUI in curved canals.

Extracellular vesicles can both worsen and help treat age-related diseases and are useful for early diagnosis.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

The EVInews database provides significantly higher quality information than web-based sources for pharmacists.

The combination of a plant extract and a peptide can increase hair pigmentation and may reverse greying.

Laser treatments are the most effective for porokeratotic adnexal ostial nevus.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Goat placenta extract in a special delivery system improved hair growth and thickness in chemotherapy patients.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.